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Surgical IVeatment of Medullary Thyroid Carcinoma in a ThirteenYear-Old Girl with MEN 2B
Lars-Erik Tisell,* and Svante Jansson*

Patients with palpable medullary thyroid carcinoma (MTC) have lymph node metastases in 90% of
cases. In most series such patients continue to have elevated serum calcitonin (CT) levels after surgery
indicating residual tumor tissue. We attempted a microdissection technique for the treatment of MTC.
' 'Micro'' refers not to a small incision or a limited exploration but to a more safe operation associated
wilh good Ughting arui magnification and minimal bleeding. This technique was used in a 13-year-old
girl with multiple endocrine neoplasia type 2B (MEN 2B). The prognosis for MTC in MEN 2B is worse
than for sporadic MTC and the MTC of MEN 2A. Every possible effort should be nmde to remove all
tumor tissue in MEN 2B patients with MTC. In this case the pathologist found bilateral MTC and
metastases in eight of 129 lymph nodes removed. The preoperative stimulated CT levels, which were
markedly elevated, decreased to near normal postoperatively. (Henry Ford Hosp Med J
1989;37:157-9)

T

he American Joint Committee on Cancer found the ten-year
survival rate in patients with medullary thyroid carcinoma
(MTC) to be only 49% (1), This finding suggested that the diagnosis and treatment of patients with MTC was far from optimal.
The prognosis for patients with hereditary MTC has been considerably improved by the introduction of screening for hypercalcitoninemia in family members at risk for developing MTC
(2-4), The only effective treatment in MTC is surgery. If the surgical technique can be improved, the prognosis of MTC should
also be further improved.
Patients with palpable MTC have lymph node metastases in
90% of cases (4). In most series such patients continue to have
elevated seram calcitonin (CT) levels after surgery indicating residual tumon We have worked out a microdissection technique
forthe treatment of MTC (5). "Micro" does not indicate a small
incision or a limited exploration but a safe operation provided by
good lighfing and magnification and minimal bleeding.t We
performed this microdissection technique on a 13-year-oId giri
with MTC as part of the hereditary syndrome of multiple endocrine neoplasia type 2B (MEN 2B). The prognosis for MTC
when it occurs as part of MEN 2B is worse than for both the
sporadic and MEN 2A varieties (6).

Case History
The father of the patient had his first operafion—a subtotal
thyroidectomy and a limited node dissection—for palpable
symptomatic bilateral MTC in 1971 when he was 31 years old.
Postoperatively he received radiation treatment to the neck region in a dose of 10 Gy. In 1977 recunent tumor was diagnosed,
and he was refened to our surgical unit for further treatment.
The thyroidectomy was completed and neck dissection performed. Postoperatively his CT levels remained elevated, and in
1987 liver metastases were diagnosed. He had a bilateral adre-
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nalectomy for pheochromocytomas. He has ganglioneuromatosis of the eyelids and gastrointestinal tract and also a marfanoid
habitus as evidence of MEN 2B (7). The liver metastases were
treated by embolizations of the hepatic arteries, and at present
his disease is stable. He is not married, and we did not discover
that he had a daughter until 1987 when she was 13 years otd.
The daughter was found to have ganglioneuromatosis of the
eyelids, tips, and tongue indicating that she had inherited MEN
2B. She had palpable bilateral thyroid tumors and markedly elevated basal and provoked CT tevels (Fig 1). Her urinary excretion of catecholamines was within normal limits on repeated
testing, and her adrenal glands were of normal size and appearance on computed tomography.

The Operation
Good lighting was provided by the use of a headlamp, and
good hemostasis was obtained by the use of unipolar and bipolar
electrical cauterization. An anatomical dissection was done
without dividing the strap or the sternocleidomastoid muscles.
The operative field included the central compartment from the
hyoid bone down to the brachiocephalic veins and the lateral regions on both sides from the mastoid process downwards including the jugular chain, the cervical nerve plexus, and the su-
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tThe technique was demonstrated on a video presented at the Third Intemational Workshop of Multiple Endocrine Neoplasia Type 2 Syndromes in Heidelberg. West Germany.
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Fig I—Serum calcitonin (CT) levels ofthe 13-year-old girl who
had MTC as part of the MEN 2B syndrome. The provoked CT
level is the highest value ofthe samples taken 2 and 5 minutes
after intravenous injection of calcium gluconate solution (10%),
2 mgCa^^Ikg body weightl60 sec, followed by an intravenous
bolus injection of pentagastrin, 0.6 [xglkg body weight.
practavicular fossa. Vessels and nerves were identified and dissected free from fat and lymph nodes. The identified nerves included the superior and inferior laryngeal nerves, vagus,
phrenic, and accessory nerves, and the bundles of the cervical
plexus. Atl the removed tissue specimens were sent to the pathologist for examination, and their anatomic locations were
carefully recorded to facilitate the mapping of the primary tumors and metastases.
The histopathologic investigation was made on paraffin-embedded specimens. Routine staining was done with van Gieson and
hematoxylin-eosin. Amyloid was demonstrated with alkaline
Congo red staining. The peroxidase-antiperoxidase (PAP) method
was used for visualization of CT immunoreactivity.
CT determinations were performed preoperatively basally
and after provocation with an intravenous bolus dose of pentagastrin. Postoperatively and at follow-up the combined short
calcium and pentagastrin test was performed as described by
Welts et at (8). The samptes were assayed at a commerciat laboratory (Immuntaboratoriet AB, Matmo, Sweden). The upper
limit of nonnal was 300 ng/L.

Results
The histopathologic examination demonstrated bilateral MTC
and C-cell hyperplasia. The tumors in both lobes had diameters
of about 1 cm. Of the 129 lymph nodes removed, eight contained
metastatic tumor. Bilateral central and lateral neck metastases
were noted. The PAP method demonstrated CT immunoreactivity both in the thyroid tumors and in the lymph node
metastases.
The resutts of CT testing are shown in Fig 1. Preoperatively
the CT levels were markedly high. Postoperatively the peak and
basal CT levets were betow the upper normal timit. However, the
peak value was 40% higher than the basal vatue which is noteworthy in a patient who had had a totat thyroidectomy.
Two years after the operation the CT levels were definitety elevated with a peak value 100% higher than the basal value. The
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Fig 2—This is a typical appearance of a MEN 2B patient. Note
the nodular tongue and lips as a result of submucosal neuromatous involvement.
serum vatue of carcinoembryonic antigen (CEA) was 34 p,g/L
preoperatively as compared to an upper reference limit of < 5
p-g/L. After surgery the CEA tevel was normal and has remained
normal during the two-year follow-up period. Despite the extensive surgery, a good cosmetic resutt was achieved.

Discussion
In our MTC series consisting of 101 operated patients, we have
encountered only four patients with MEN 2B, two of whom
have been reviewed here. The other two MEN 2B patients died
from metastasizing MTC at ages 42 and 46 years. Neither of
these deceased patients had children.
During the tast 18 years, when MTC patients have been more
systematically treated and diagnosed at our clinic, only one of
our 44 patients having MTC as part of the MEN 2A syndrome
has died from MTC. The relatives of that patient had thought that
he should not be bothered by any screening examinations because he was mentally retarded. When his disease was diagnosed he could onty take liquids and was emaciated. At surgery
he was found to have MTC infiltrating and constricring the
esophagus and trachea and thus onty a palliative procedure
could be performed. He died three years tater as a resutt of progressive tumor growth.
During these 18 years, 15% of our sporadic MTC patients died
from MTC (4). Our experience with the MEN 2B patients concurs with that of other reports indicating that the MEN 2B variety of MTC has the worst prognosis (6). In about 50% of cases
the MEN 2B appears to be sporadic whereas in the remainder it
is inherited as an autosomal dominant trait (9,10). Sporadic
MEN 2B cases are diagnosed by their typical appearance, with a
marfanoid habitus, an egg-shaped head, and thick nodular tips
(Fig 2).
Camey et at (7) reported two hereditary MEN 2B cases, aged
2 and 5 years. Both had elevated CT levels. The older pafient had
MTC, and the younger patient had C-cett hyperplasia. Other reports atso indicate a tower age at diagnosis in MEN 2B com-

Surgical Treatment of MTC—Tisell & Jansson

pared to MEN 2A patients (6,9). The early onset of disease in
MEN 2B patients is illustrated by the finding of metastasizing
MTC in our 13-year-old patient. After surgery she has only minimally elevated provoked CT levels. She will require close follow-up, and if more substantial elevations of CT levets occur she
can be offered repeated surgery with the hope of a biochemical
cure (4,5). This case illustrates that good surgical results can be
obtained even in cases with metastases and emphasizes that
every effort should be made to trace all MEN 2B relatives and
offer screening for MTC. In children such screening should start
by age 5 years whenever possible.
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